Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
40 participants
INTERVENTIONAL
2019-04-01
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer
NCT03645187
The Impact of Metformin Administration on the Clinical Outcome of Stage IV Colon Cancer
NCT05921942
A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer
NCT03035253
ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
NCT00385021
Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer
NCT05868317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Folfox with avastin
Folfox with avastin only
Folfox with avastin
Folfox with avastin only
Mebendazole
Folfox with avastin with mebendazole
Mebendazole
Folfox with avastin with mebendazole
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Folfox with avastin
Folfox with avastin only
Mebendazole
Folfox with avastin with mebendazole
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Allergy to mebendazole.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reham El-ghoneimy, Msc
Role: PRINCIPAL_INVESTIGATOR
Tanta University - Faculty of Pharmacy
Sahar Hegazy, Prof
Role: PRINCIPAL_INVESTIGATOR
Tanta University - Faculty of Pharmacy
Gamal el-azab, Prof
Role: STUDY_DIRECTOR
Tanta University - Faculty of Pharmacy
Fatma Zakaria, Prof
Role: STUDY_CHAIR
Tanta University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sherief Abd-Elsalam
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hegazy SK, El-Azab GA, Zakaria F, Mostafa MF, El-Ghoneimy RA. Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer. Life Sci. 2022 Jun 15;299:120536. doi: 10.1016/j.lfs.2022.120536. Epub 2022 Apr 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
colon cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.